Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )
© 2018 The Authors. American Journal of Hematology published by Wiley Periodicals, Inc. β-Thalassemia, a hereditary blood disorder caused by reduced or absent synthesis of the β-globin chain of hemoglobin, is characterized by ineffective erythropoiesis, and can manifest as nontransfusion-dependent...
محفوظ في:
المؤلفون الرئيسيون: | Ali Taher, Vip Viprakasit, Maria Domenica Cappellini, Pranee Sutcharitchan, Richard Ward, Dalia Mahmoud, Abderrahmane Laadem, Anzalee Khan, Chad Gwaltney, Gale Harding, Kenneth Attie, Xiaosha Zhang, Jun Zou, Joseph Pariseau, X. Henry Hu, Antonis Kattamis |
---|---|
مؤلفون آخرون: | Evidera, USA |
التنسيق: | مقال |
منشور في: |
2020
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://repository.li.mahidol.ac.th/handle/123456789/51936 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )
بواسطة: Ali Taher, وآخرون
منشور في: (2020) -
Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand
بواسطة: Maria Domenica Cappellini, وآخرون
منشور في: (2020) -
Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
بواسطة: Ali T. Taher, وآخرون
منشور في: (2018) -
Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later
بواسطة: Khaled M. Musallam, وآخرون
منشور في: (2022) -
Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo
بواسطة: Ali T. Taher, وآخرون
منشور في: (2018)